Validated liquid chromatographic determination of 5-fluorouracil in human plasma

被引:53
作者
Alsarra, IA
Alarifi, MN
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh 11451, Saudi Arabia
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 804卷 / 02期
关键词
5-fluorouracil;
D O I
10.1016/j.jchromb.2004.01.043
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive, reproducible, selective and accurate high performance liquid chromatographic (HPLC) method for the quantitative determination of 5-flurorouracil in plasma has been developed and validated using isocratic elution and UV detection. The method provides a selective quantifications of 5-flurorouracil without any interference of the endogenous uracil. The assay is performed after a double extraction of 5-flurorouracil and thymine (internal standard) from human plasma using ethyl acetate. The drug and the internal standard were eluted from a Genesis C-18 analytical column at ambient temperature with mobile phase consisting of methanol:water (10:90, v/v) adjusted to pH 3.2 with perchloric acid at a flow rate of 1.0 ml/min. The effluent was monitored with an ultraviolet detector at 260 nm. Quantification was achieved by the measurement of the peak-height ratios and the limit of quantification for 5-flurorouracil in plasma was 30 ng/ml. The retention times for 5-flurorouracil, uracil, and thymine were 4.5, 6.0, and 9.0, respectively. The intra-day coefficient of variation (CV) ranged from 1.35 to 4.53% at three different concentrations and the inter-day CVs varied from 1.29 to 4.98%. The relative and absolute recoveries varied from 96 to 101%. Stability tests showed that 5-flurorouracil is stable for at least 72 h in plasma after freezing. The simple method may permit the assessment of 5-flurorouracil plasma concentrations for pharmacokinetic studies in combination with clinical trials. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:435 / 439
页数:5
相关论文
共 16 条
[1]   Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography [J].
Ackland, SP ;
Garg, MB ;
Dunstan, RH .
ANALYTICAL BIOCHEMISTRY, 1997, 246 (01) :79-85
[2]   Simultaneous gas chromatographic mass spectrophotometric determination of alpha-fluoro-beta-alanine and 5-flaorouracil in plasma [J].
Anderson, D ;
Kerr, DJ ;
Blesing, C ;
Seymour, LW .
JOURNAL OF CHROMATOGRAPHY B, 1997, 688 (01) :87-93
[3]  
[Anonymous], J CHROMATOGR
[4]  
CAO S, 1995, CANCER RES, V55, P6227
[5]   Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma [J].
Compagnon, P ;
Thiberville, L ;
Moore, N ;
Thuillez, C ;
Lacroix, C .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (02) :380-383
[6]   High-performance liquid chromatographic assay for the determination of haloperidol in plasma [J].
ElSayed, YM ;
Khidr, SH ;
Niazy, EM .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1996, 19 (01) :125-134
[7]  
*FDA, 2001, GAUD IND BIOAN METH
[8]   Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma [J].
Gamelin, E ;
BoisdronCelle, M ;
Turcant, A ;
Larra, F ;
Allain, P ;
Robert, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 695 (02) :409-416
[9]   Simultaneous determination of 5-fluorouracil and uracil by high-performance liquid chromatography using four serial columns [J].
House, LK ;
Ramírez, J ;
Ratain, MJ .
JOURNAL OF CHROMATOGRAPHY B, 1998, 720 (1-2) :245-250
[10]   Treatment of colorectal cancer - Current guidelines and future prospects for drug therapy [J].
Labianca, R ;
Pessi, MA ;
Zamparelli, G .
DRUGS, 1997, 53 (04) :593-607